	US 12,414,920 B2
	Spray-dried blood products and methods of making same
Thomas H. Fischer, Durham, NC (US); Joseph A DaCorta, Durham, NC (US); and Michael Lawrence Galiger, Durham, NC (US)
Assigned to Velico Medical Inc., Beverly, MA (US)
Filed by Velico Medical, Inc., Beverly, MA (US)
Filed on Dec. 30, 2021, as Appl. No. 17/566,226.
Application 17/566,226 is a division of application No. 15/872,727, filed on Jan. 16, 2018, granted, now 11,213,488.
Application 15/872,727 is a continuation of application No. 13/262,931, granted, now 9,867,782, issued on Jan. 16, 2018, previously published as PCT/US2010/030031, filed on Apr. 6, 2010.
Claims priority of provisional application 61/212,321, filed on Apr. 9, 2009.
Prior Publication US 2022/0117897 A1, Apr. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/16 (2006.01); A61F 13/00 (2024.01); A61K 9/00 (2006.01); A61K 35/16 (2015.01); A61K 35/19 (2015.01); A61L 15/40 (2006.01); A61L 26/00 (2006.01)

CPC A61K 9/1688 (2013.01) [A61F 13/00063 (2013.01); A61K 9/0026 (2013.01); A61K 35/16 (2013.01); A61K 35/19 (2013.01); A61L 15/40 (2013.01); A61L 26/0047 (2013.01); A61L 26/0057 (2013.01); A61L 26/0076 (2013.01); A61F 2013/00306 (2013.01); A61F 2013/00472 (2013.01); A61F 2013/00927 (2013.01)]

12 Claims

1. A method of preparing dehydrated plasma, comprising the steps of:

a) providing hydrated plasma; and

b) spray drying said hydrated plasma at a temperature of at least about 110° C. to produce dehydrated plasma wherein one or more coagulation factors are retained after drying.